OpenAlex
PricingAboutJobs
Log inGet started
Author

Vikas Ostwal

Observed name: V. Ostwal
Institutions: Homi Bhabha National Institute, Tata Memorial Hospital
Observed institutions: Homi Bhabha National Institute, Tata Memorial Hospital
ORCID: 0000-0002-0067-4748
Observed ORCID: 0000-0002-0067-4748
OpenAlex ID: A5125466504
Durvalumab and tremelimumab, with or without lenvatinib, combined with transarterial chemoembolisation in participants with embolisation-eligible hepatocellular carcinoma (EMERALD-3): a global, randomised, open-label, sponsor-blinded, phase 3 study
2026 · Masatoshi Kudo, Ghassan K Abou-Alfa, et al. · The Lancet Oncology · 6
Expression of Concern: Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric Trial
2026 · Vikas Ostwal, Manali Parulekar, et al. · JCO Global Oncology
PDF
Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric Trial
2026 · Vikas Ostwal, Manali Parulekar, et al. · JCO Global Oncology
Comparative outcomes with low-dose and standard-dose immune checkpoint inhibitors in microsatellite stable advanced gastric/gastroesophageal adenocarcinoma
2026 · A. Ramaswamy, V. Shenoy, et al. · ESMO Gastrointestinal Oncology
PDF
Works count: 4
Citation count: 6
H-index: 1
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security